Publications by authors named "Jim Canet"

Article Synopsis
  • * The research included 507 patients diagnosed between 2006 and 2016, revealing that 22% participated in clinical trials, and overall survival pathways varied while some patients transitioned to second-line treatments or stopped therapy.
  • * Despite showing improvements in initial responses for NG-TKI, the study did not definitively conclude that NG-TKI is superior to IM in terms of survival and tolerance, indicating that further research is necessary. *
View Article and Find Full Text PDF

Limiting exposure to environmental hazards during preconception and pregnancy is essential for preventing adverse pregnancy outcomes or developmental defects in offspring. However, the perception of environmental risk and the behavioral changes of women planning or having a pregnancy have rarely been investigated, except for a few risk factors. We thus performed a cross-sectional study of French postpartum women hospitalized in the Bordeaux University Hospital in 2017 by proposing a self-administrated survey.

View Article and Find Full Text PDF

Supplementary Table 1 and the Supplementary Figure legends were not included when this manuscript was first published. The files are now available here.

View Article and Find Full Text PDF

Background: Metastatic colorectal cancer (mCRC) patients with mutant KRAS or NRAS are ineligible for anti-epidermal growth factor receptor (anti-EGFR) therapy, as RAS mutations activate downstream pathways independently of EGFR and induce primary resistance. However, even among RAS wild-type (WT) patients, only a fraction responds to anti-EGFR therapy, suggesting that other mechanisms of resistance exist. We hypothesise that different (epi)genetic alterations can lead to primary anti-EGFR resistance and that the crucial end point is the activation of protein signalling pathways.

View Article and Find Full Text PDF